Global Fetal Heart Rate Monitoring Device Market to reach USD XX billion by 2027.Global Fetal Heart Rate Monitoring Device Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.70% over the forecast period 2021-2027. Fetal heart rate monitoring is a procedure that uses specific equipment to measure and monitor the baby's heart rate and rhythm during labour and delivery. Fetal heart rate monitoring is often utilized in obstetrics and gynaecology. It is critical in foetal care, particularly during the intrapartum period. Fetal heart rate monitoring during a high-risk pregnancy decreases foetal or neonatal death and helps in the prevention of severe neonatal asphyxia and infantile cerebral palsy (CP) caused by foetal hypoxia. Furthermore, it assists in the detection and monitoring of any deviation from the usual heart rate rhythm during birth. The increasing birth rate and preterm births, as well as increased government and non-government activities to provide better mother and fetus care, are all contributing to market growth. Furthermore, the technical progress in monitoring devices, with a major focus on patient care and comfort, is expected to fuel market growth. According to the National Center for Science and Engineering Statistics (NCSES) report, healthcare R&D investment in the United States increased by 5.7 percent from 2018 to 2019. Furthermore, the Canadian government established around 73 initiatives as support of the Maternal, Newborn, and Child Health (MNCH) programme, with the goal of improving the health of mothers and children. However, high cost associated with fetal heart rate monitoring devices, may impede market growth over the forecast period of 2021-2027.

North America, that includes the United States and Canada, has one of the most well-structured, developed, and advanced healthcare systems in the world. With significant R&D spending on newborn care equipment, governments in the North American region are also encouraging small-scale healthcare research facilities. Therefore, many companies are encouraged to operate in the region, making North America dominating the market across the world.

Major market player included in this report are:
Philips Healthcare
GE Healthcare
Trismed Co, Ltd
Sunray Medical Apparatus Co.
MedGyn Products Inc.
Fujifilm Sonosite Inc.
Edan Instruments
CooperSurgical Inc.
Bionet America
Mindray Medical


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product Product types of key players. The detailed segments and sub-segment of the market are explained below:

By Product type:
Internal Heart Rate Monitoring Device
External Heart Rate Monitoring Device
By Technology type:
Doppler Ultrasound Device
Electronic Fetal Monitoring Device
By Portability type:
Portable
Non-portable
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Fetal Heart Rate Monitoring Device Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors